770 results on '"Poon, Ronnie T"'
Search Results
2. Supplementary Table 3 from Circulating Oncometabolite 2-Hydroxyglutarate Is a Potential Surrogate Biomarker in Patients with Isocitrate Dehydrogenase-Mutant Intrahepatic Cholangiocarcinoma
3. Supplementary Table 2 from Circulating Oncometabolite 2-Hydroxyglutarate Is a Potential Surrogate Biomarker in Patients with Isocitrate Dehydrogenase-Mutant Intrahepatic Cholangiocarcinoma
4. Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
5. Serine peptidase inhibitor Kazal type 1 (SPINK1) as novel downstream effector of the cadherin-17/β-catenin axis in hepatocellular carcinoma
6. Quality of life changes in patients undergoing treatment for hepatocellular carcinoma
7. Decoding complex patterns of genomic rearrangement in hepatocellular carcinoma
8. Suppression of Slit3 induces tumor proliferation and chemoresistance in hepatocellular carcinoma through activation of GSK3β/β-catenin pathway
9. Cyclins and CDKs in Liver Diseases
10. HIVID: An efficient method to detect HBV integration using low coverage sequencing
11. Differences in health‐related quality of life between European and Asian patients with hepatocellular carcinoma
12. Pure Laparoscopic Versus Open Left Lateral Sectionectomy for Hepatocellular Carcinoma: A Single-Center Experience
13. Modified Anterior Approach for the ALPPS Procedure: How We Do It
14. Comparison of Survival Outcomes Between Right Posterior Sectionectomy and Right Hepatectomy for Hepatocellular Carcinoma in Cirrhotic Liver: A Single-Centre Experience
15. Preliminary efficacy, safety, pharmacokinetics, pharmacodynamics and quality of life study of pegylated recombinant human arginase 1 in patients with advanced hepatocellular carcinoma
16. Phase I Study of Heat-Deployed Liposomal Doxorubicin during Radiofrequency Ablation for Hepatic Malignancies
17. Efficacy of radiofrequency ablation compared with transarterial chemoembolization for the treatment of recurrent hepatocellular carcinoma: a comparative survival analysis
18. DLK1-DIO3 Genomic Imprinted MicroRNA Cluster at 14q32.2 Defines a Stemlike Subtype of Hepatocellular Carcinoma Associated with Poor Survival
19. Prognostic Marker MicroRNA-125b Inhibits Tumorigenic Properties of Hepatocellular Carcinoma Cells Via Suppressing Tumorigenic Molecule eIF5A2
20. Treatment Strategy to Improve Long-Term Survival for Hepatocellular Carcinoma Smaller than 5 cm: Major Hepatectomy vs Minor Hepatectomy
21. Feasibility of Laparoscopic Re-resection for Patients with Recurrent Hepatocellular Carcinoma
22. Retrospective study of metachronous lung metastases from primary hepatocellular carcinoma
23. A Subpopulation of CD26 + Cancer Stem Cells with Metastatic Capacity in Human Colorectal Cancer
24. Laparoscopic Liver Resection for Hepatocellular Carcinoma
25. Outcomes of hepatectomy for hepatocellular carcinoma with bile duct tumour thrombus
26. Radiofrequency ablation versus transarterial chemoembolization for unresectable solitary hepatocellular carcinomas sized 5–8 cm
27. Surgical Outcomes in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis
28. PTK787/ZK22258 attenuates stellate cell activation and hepatic fibrosis in vivo by inhibiting VEGF signaling
29. A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma
30. Improved Long-Term Survival after Major Resection for Hepatocellular Carcinoma: A Multicenter Analysis Based on a New Definition of Major Hepatectomy
31. Phase II study of bevacizumab and erlotinib in the treatment of advanced hepatocellular carcinoma patients with sorafenib-refractory disease
32. Tolerance of High-Intensity Focused Ultrasound Ablation in Patients with Hepatocellular Carcinoma
33. Survival advantage of primary liver transplantation for hepatocellular carcinoma within the up-to-7 criteria with microvascular invasion
34. Primary perivascular epithelioid cell tumour (PEComa) of the liver
35. Survival Analysis of Re-resection Versus Radiofrequency Ablation for Intrahepatic Recurrence After Hepatectomy for Hepatocellular Carcinoma
36. An N-terminal truncated carboxypeptidase E splice isoform induces tumor growth and is a biomarker for predicting future metastasis in human cancers
37. Analysis of Recurrence Pattern and Its Influence on Survival Outcome After Radiofrequency Ablation of Hepatocellular Carcinoma
38. Enhanced Detection of Early Hepatocellular Carcinoma by Serum SELDI-TOF Proteomic Signature Combined with Alpha-Fetoprotein Marker
39. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma
40. Recent Advances in the Prevention of Hepatocellular Carcinoma Recurrence
41. Analysis of long-term survival after hepatectomy for isolated liver metastasis of gastrointestinal stromal tumour
42. Trans-arterial chemo-embolization is safe and effective for elderly advanced hepatocellular carcinoma patients: results from an international database
43. Good longterm survival after primary living donor liver transplantation for solitary hepatocellular carcinomas up to 8 cm in diameter
44. Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib: The EVOLVE-1 Randomized Clinical Trial
45. Survival analysis of high-intensity focused ultrasound therapy vs. transarterial chemoembolization for unresectable hepatocellular carcinomas
46. Survival outcome of re-resection for recurrent liver metastases of colorectal cancer: a retrospective study
47. Laparoscopic versus open liver resection for elderly patients with malignant liver tumors: A single-center experience
48. Tolerance of radiofrequency ablation by patients of hepatocellular carcinoma
49. An Update on Long-Term Outcome of Curative Hepatic Resection for Hepatocholangiocarcinoma
50. Biology of Hepatocellular Carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.